Invivotek
Invivotek offers both custom and standard preclinical services for drug discovery and development programs for their clients. Services offered by Invivotek include studies involving animal models and bioassays to test compounds related to immunology and inflammation, oncology, metabolic and cardiovascular diseases. Invivotek's in vivo testing capabilities are supported by biochemical and molecular biology techniques, as well as by functional assays with primary cell cultures. These assays provide tools to study the mechanisms of drug action and to explore biomarkers for drug efficacy. Invivotek offers over a hundred assays and models across multiple therapeutic areas, with a special focus on advanced models including metastatic cancer, immuno-oncology, autoimmune and metabolic diseases. Invivotek's experience across multiple therapeutic areas and its efficient project management, positions the company as a leading provider of preclinical in vivo services.
About Invivotek
Founded
2012Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$350KCategory
Industry
BiotechnologyLocation
City
TrentonState
New JerseyCountry
United StatesInvivotek
Find your buyer within Invivotek